Surgical Techniques for Retinal Gene Therapy Delivery

Subretinal injection prevails; other methods are being explored.

By Kenneth C. Fan, MD, MBA

Gene Therapy for Inherited and Rare Retinal Disease

The number of clinical trials is growing.

By Alex Yuan, MD, PhD

Suprachoroidal Gene Transfer

A noninvasive approach to transduce photoreceptors and retinal pigment epithelium.

By Peter A. Campochiaro, MD

Gene Therapy for Neovascular AMD

An update on ongoing clinical trials.

By Fawwaz Siddiqui, BS, Aamir A. Aziz, BS, Arshad M. Khanani, MD, MA, FASRS

Vector Considerations for Ocular Gene Therapy

Adeno-associated virus vectors offer a safe and effective tool for gene delivery.

By Szilárd Kiss, MD

UPFRONT: A Focus on Gene Therapy

By Peter K. Kaiser, MD

GUEST EDITORIAL: Innovations in Ocular Gene Therapy

GUEST EDITORS, RETINAL PHYSICIAN SPECIAL ISSUE ON GENE THERAPY

By Peter A. Campochiaro, MD, Arshad M. Khanani, MD, MA, FASRS, Rishi P. Singh, MD

SPONSOR LETTER: Gene Therapy for Rare and Chronic Diseases

It's time for industry pioneers to think boldly and broadly.

By Kenneth T. Mills, President and CEO, Regenxbio

FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina

By Jerry Helzner, contributing editor

CODING Q&A: EO Codes at Last Get a Revamp

New codes are differentiated by anatomy.

By Suzanne L. Corcoran, COE

CONTROVERSIES IN CARE: Initiating Anti-VEGF in Patients With DME and Good Vision

Protocol V data could inform timing of treatment.

By Michael Colucciello, MD, David S. Boyer, MD, Pravin U. Dugel, MD

RETINA CONVERSATIONS: A Historical Perspective on Gene Therapy for Retinal Disease

A discussion with Mark Pennesi, MD, PhD.

By Jerry Helzner, contributing editor

CLINICAL TRIAL DOWNLOAD: Phase 2b Data for a C5 Inhibitor

Encouraging data support the complement system as a target for geographic atrophy.

By Pravin U. Dugel, MD

NEW PRODUCT APPLICATIONS: Bringing Automation to Fluorescein Angiography Systems

As a true-color sensor, this confocal scanner is the only one of its kind.

By Karen Appold, contributing writer

CLINICAL TRIAL UPDATE

SUBSPECIALTY NEWS: Stem-cell therapy for geographic atrophy, artifacts in OCTA, European opinion for Beovu, and more.

By Jerry Helzner, contributing editor

The Eye as a Biofactory

The next phase of gene therapy.

By M. Ali Khan, MD, Allen C. Ho, MD